Diamond Biotechnology Co., Ltd (TPEX:6815)
15.45
+6.49 (72.39%)
At close: Nov 20, 2026
Diamond Biotechnology Market Cap
Diamond Biotechnology has a market cap or net worth of 613.44 million as of November 20, 2026. It is the 36,977th most valuable company in the world and the 2,182nd biggest in Taiwan. Its market cap has decreased by 75.10% in one year.
Market Cap
613.44M
Enterprise Value
571.59M
Revenue
464.63M
Global Rank
Country Rank
#2,182 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since January 29, 2021, Diamond Biotechnology's market cap has decreased from 1.68B to 613.44M, a decrease of -63.50%. That is a compound annual growth rate of -15.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 613.44M | -75.50% |
| Dec 31, 2025 | 2.50B | -7.50% |
| Dec 31, 2024 | 2.71B | 12.05% |
| Dec 29, 2023 | 2.42B | 179.34% |
| Dec 30, 2022 | 864.86M | -11.33% |
| Dec 30, 2021 | 975.37M | -41.97% |
| Jan 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| S&S Healthcare Holding | 1.12B |
| Wiltrom | 846.37M |
| Rossmax International | 820.03M |
| Radiant Innovation | 745.23M |
| AmCad BioMed | 699.83M |
| Carilex Medical | 651.76M |
| Cowealth Medical Holding | 635.72M |
| PlexBio | 518.25M |